巴塞罗那生物心力衰竭风险计算器可以预测晚期心力衰竭患者的1年死亡率
Wioletta Szczurek-Wasilewicz1, Michał Skrzypek2, Andrzej Karmański3
1Silesian Center for Heart Diseases, Zabrze, Poland
Polish archives of internal medicine
|May 28, 2024
概括
巴塞罗那生物心力衰竭 (BCN Bio-HF) 风险计算器在预测末期心力衰竭患者1年死亡率方面表现出卓越的准确性,与传统得分相比. 较高的胆红素水平也表明预后更差.
科学领域:
- 心脏病学 心脏病学
- 生物医学工程 生物医学工程
- 临床研究 临床研究
背景情况:
- 准确的风险评估对于管理心力衰竭 (HF) 患者至关重要.
- 新型生物标志物与临床变量相结合,可以改善高频率患者的预后评估.
- 末期肝炎患者需要精确的工具来预测结果.
研究的目的:
- 评估巴塞罗那生物心力衰竭 (BCN Bio-HF) 风险计算器的预测性能.
- 为了将 BCN Bio-HF 与传统的评分比较,例如心力衰竭生存评分 (HFSS) 和西雅图心力衰竭模型 (SHFM).
- 为了确定最终阶段HF死亡的额外风险因素.
主要方法:
- 对279名等待心脏移植 (2018-2021) 的末期高血压患者进行前性分析.
- 为所有参与者计算NCB Bio-HF,HFSS和SHFM分数.
- 接收器操作特征 (ROC) 分析,以评估1年死亡率预测的准确性.
主要成果:
- BCN Bio-HF得分实现了0.95的ROC曲线下的区域,明显优于HFSS (0.81) 和SHFM (0.7).
- BCN Bio-HF和HFSS得分,以及循环胆红素度,独立地与1年死亡率有关.
- 34.1%的患者 (95/279) 在1年的随访期内死亡.
结论:
- BCN生物-HF风险评分为末期HF患者提供了比HFSS和SHFM更好的预后性能.
- 较低的BCN Bio-HF和HFSS得分与1年死亡风险的增加有关.
- 升高的胆红素水平是该患者队列中死亡率的独立预测因素.
相关概念视频
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:22Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
01:20Actuarial Approach
75
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
75
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421